You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽升藥業(300485.SZ):擬以1億元設安牛牧業生物科技
格隆匯 05-12 15:57

格隆匯5月12日丨賽升藥業(300485.SZ)公佈,根據公司戰略規劃及業務發展需要,公司於2022年5月12日召開第四屆董事會第十七次會議,審議通過了《關於對外投資設立全資子公司的議案》,同意公司以自有資金1億元出資設立全資子公司“吉林省安牛牧業生物科技有限公司”(暫定名,最終以工商登記為準)。

公司出於戰略規劃實施此次投資。此次投資將推動公司拓展種牛培育、體外胚胎技術應用、基因編輯等生物育種業務領域開發,進一步推進公司生命科學及大健康領域的戰略佈局,此次對外投資將為公司的持續穩健發展提供更多的機會,有助於提升公司的對外投資收益水平,符合公司及全體股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account